<?xml version="1.0" encoding="UTF-8"?>
<p>Bufadienolides have also been described as potent anticancer agents, as demonstrated by a number of in vitro studies with multiple cancer cell lines (
 <xref rid="pharmaceuticals-13-00444-t004" ref-type="table">Table 4</xref>) [
 <xref rid="B120-pharmaceuticals-13-00444" ref-type="bibr">120</xref>]. Nevertheless, their inherent toxicity difficult their administration in animal and human models [
 <xref rid="B121-pharmaceuticals-13-00444" ref-type="bibr">121</xref>]. Current research on these compounds is focused on finding effective and safer semi-synthetic derivatives [
 <xref rid="B122-pharmaceuticals-13-00444" ref-type="bibr">122</xref>].
</p>
